Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:16 AM
Ignite Modification Date:
2025-12-25 @ 12:16 AM
NCT ID:
NCT02594358
Eligibility Criteria:
Inclusion Criteria:
* Amblyopia from strabismus and amblyopia
Exclusion Criteria:
* Known intolerance to caffeine
* Diagnosis and/or treatment of attention deficit/hyperactivity disorder
* Presence of an ocular cause for reduced visual acuity
* Myopia with a special equivalent -6.00 diopters
* Current vision therapy or orthoptics - any type
* Ocular cause for reduced visual acuity
* Prior intraocular or refractive surgery
* History of narrow-angle glaucoma
* Strabismus surgery planned within 16 weeks
* Nystagmus per se does not exclude the subject if the above visual acuity criteria are met
* Known skin reactions to patch or bandage adhesives
* Known allergy or intolerance to food dyes
* Current treatment with topical atropine eyedrops
* Menarche, pregnancy or lactation
* Use of any of the following medications which may affect caffeine metabolism: nafcillin, verapamil, fluvoxamine, ciprofloxacin and other fluoroquinolones, modafinil, nafcillin, and omeprazole
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
7 Years
Maximum Age:
13 Years
Study:
NCT02594358
Study Brief:
Protocol Section:
NCT02594358